Wilson D. Pace

Wilson D. Pace

Auto-generated profile, based on publicly available information

Wilson D. Pace

DARTNet Institute, Aurora, CO, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
KTKaren Tu
Karen Tu
RKRobert Sarkadi Kristiansson
Robert Sarkadi Kristiansson
JGJesse Gronsbell
Jesse Gronsbell
Simon de LusignanSimon de Lusignan
Simon de Lusignan
SFSigne Flottorp
Signe Flottorp
ESEllen Stephenson
Ellen Stephenson
Introduction: Through the INT ernational Conso R tium of P rimary Care B I g D ata Researchers ( INTRePID ), we compared the pandemic impact on the volume of primary care visits and uptake of virtual care in Australia, Canada, China, Norway, Singapore, South Korea, Sweden, the UK and the USA. Methods: Visit definitions were agreed on centrally, implemented locally across the various settings in INTRePID countries, and weekly visit counts were shared centrally for analysis. We evaluated the weekly rate of primary care physician visits during 2019 and 2020. Rate ratios (RRs) of total weekly visit volume and the proportion of weekly visits that were virtual in the pandemic period in 2020 compared with the same prepandemic period in 2019 were calculated. Results: In 2019 and 2020, there were 80 889 386 primary care physician visits across INTRePID. During the pandemic, average weekly visit volume dropped in China, Singapore, South Korea, and the USA but was stable overall in Australia (RR 0.98 (95% CI 0.92 to 1.05, p=0.59)), Canada (RR 0.96 (95% CI 0.89 to 1.03, p=0.24)), Norway (RR 1.01 (95% CI 0.88 to 1.17, p=0.85)), Sweden (RR 0.91 (95% CI 0.79 to 1.06, p=0.22)) and the UK (RR 0.86 (95% CI 0.72 to 1.03, p=0.11)). In countries that had negligible virtual care prepandemic, the proportion of visits that were virtual were highest in Canada (77.0%) and Australia (41.8%). In Norway (RR 8.23 (95% CI 5.30 to 12.78, p<0.001), the UK (RR 2.36 (95% CI 2.24 to 2.50, p<0.001)) and Sweden (RR 1.33 (95% CI 1.17 to 1.50, p<0.001)) where virtual visits existed prepandemic, it increased significantly during the pandemic. Conclusions: The drop in primary care in-person visits during the pandemic was a global phenomenon across INTRePID countries. In several countries, primary care shifted to virtual visits mitigating the drop in in-person visits.

29 June 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
AFAlexander G. Fiks
Alexander G. Fiks
NDNathalie DuRivage
Nathalie DuRivage
SMStephanie Mayne
Stephanie Mayne
SFStacia Finch
Stacia Finch
MRMichelle E Ross
Michelle E Ross
RGRobert W Grundmeier
Robert W Grundmeier
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

11 December 2020 in Contemporary Clinical Trials
Verified
Journal Article
Open access
EIElliot Israel
Elliot Israel
JCJuan Carlos Cardet
Juan Carlos Cardet
JCJennifer K. Carroll
Jennifer K. Carroll
AFAnne L. Fuhlbrigge
Anne L. Fuhlbrigge
WPWilson D. Pace
Wilson D. Pace
ABAhmet Baydur
Ahmet Baydur
Asthma prevalence, morbidity, and mortality disproportionately impact African American/Black (AA/B) and Hispanic/Latinx (H/L) communities. Adherence to daily inhaled corticosteroid (ICS), recommended by asthma guidelines in all but the mildest cases of asthma, is generally poor. As-needed ICS has shown promise as a patient-empowering asthma management strategy, but it has not been rigorously studied in AA/B or H/L patients or in a real-world setting. Design and Aim The PeRson EmPowered Asthma RElief (PREPARE) Study is a randomized, open-label, pragmatic study which aims to assess whether a patient-guided, reliever-triggered ICS strategy called PARTICS (Patient-Activated Reliever-Triggered Inhaled CorticoSteroid) can improve asthma outcomes in AA/B and H/L adult patient populations. In designing and implementing the study, the PREPARE research team has relied heavily on advice from AA/B and H/L Patient Partners and other stakeholders. Methods PREPARE is enrolling 1200 adult participants (600 AA/Bs, 600H/Ls) with asthma. Participants are randomized to PARTICS + Usual Care (intervention) versus Usual Care (control). Following a single in-person enrollment visit, participants complete monthly questionnaires for 15 months. The primary endpoint is annualized asthma exacerbation rate. Secondary endpoints include asthma control; preference-based quality of life; and days lost from work, school, or usual activities. Discussion The PREPARE study features a pragmatic design allowing for the real-world assessment of a patient-centered, reliever-triggered ICS strategy in AA/B and H/L patients. Outcomes of this study have the potential to offer powerful evidence supporting PARTICS as an effective asthma management strategy in patient populations that suffer disproportionately from asthma morbidity and mortality.

24 March 2021 in Journal of Patient Safety
Verified
Journal Article
Open access
ARAmanda Rondinelli Ratigan
Amanda Rondinelli Ratigan
VMVeronique Michaud
Veronique Michaud
JTJacques Turgeon
Jacques Turgeon
RBRavil Bikmetov
Ravil Bikmetov
GVGabriela Gaona Villarreal
Gabriela Gaona Villarreal
WPWilson D. Pace
Wilson D. Pace
The use of electronic health records allows for the application of a novel medication risk score for the rapid identification of ambulatory patients at risk of adverse drug events. We sought to examine the longitudinal association of medication risk score with mortality. This retrospective cohort study included patients whose data were available through electronic health records from multiple health care organizations in the United States that provided data as part of a Patient Safety Organization. Patients were included if they had ≥1 visit and ≥1 medication in their record between January 1, 2011, to June 30, 2017. Cox proportional hazards regression was used to examine the association between continuous and categorized medication risk score with all-cause mortality. Among 427,103 patients, the median age was 50 years (interquartile range, 29–64 years); 61% were female; 50% were White, 11% were Black, and 38% were Hispanic; and 6873 had a death date recorded. Patients 30 to 49 years old had the highest hazard ratios (HRs), followed by the 50- to 64-year-olds and lastly those 65 years or older. Controlling for all covariates, 30- to 49-year-olds with a score of 20 to 30 (versus <10) had a 604% increase in the hazard of death (HR, 7.04; 95% confidence interval [CI], 3.86–12.85), 50- to 64-year-olds had a 254% increase (HR, 3.54; 95% CI, 2.71–4.63), and ≥65-year-olds had an 87% increase (HR, 1.87; 95% CI, 1.67–2.09). The medication risk score was independently associated with death, adjusting for multimorbidities and other conditions. Risk was found to vary by age group and score. Results suggest that pharmaceutical interventions among those with elevated scores could improve medication safety for patients taking multiple medications.

1 January 2014 in The Journal of the American Board of Family Medicine
Verified
Journal Article
Open access
PDF file
BYBarbara P. Yawn
Barbara P. Yawn
ADAllen Dietrich
Allen Dietrich
DGDeborah Graham
Deborah Graham
SBSusan Bertram
Susan Bertram
MKMarge Kurland
Marge Kurland
WPWilson Pace
Wilson Pace
Introduction: Practice-based research continues to evolve and has become a major methodology for many pragmatic studies. While early practice-based network projects were usually short term, current studies often introduce or compare practice innovations that require long-term evaluation. That change requires that practice sites remain engaged in research work for up to 5 years, a time that can allow for a significant “voltage drop,” or decline in active participation. Methods: Over the past 15 years we have developed and adapted several strategies to facilitate and encourage the continued active engagement of practices in practice-based research network studies of up to 5 years' duration. The concepts, details, evaluation, and results (when available) of the strategies are described. Results: Eight strategies that enhance practice sites' attention to enrollment, data collection and continued use of the implemented practice change are described. Conclusion: The loss of momentum, or “voltage drop,” that happens in longer-term practice-based research network studies can be addressed using multiple strategies.

23 May 2018 in Translational Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
NLNatalia Y Loskutova
Natalia Y Loskutova
ATAdam G Tsai
Adam G Tsai
ECElisabeth Callen
Elisabeth Callen
KAKemi Ajayi
Kemi Ajayi
JCJennifer K Carroll
Jennifer K Carroll
WPWilson D Pace
Wilson D Pace
Chronic conditions such as type 2 diabetes are challenging to manage. This is often due to failure of both the practice of effective diabetes self-care management by the patient and inadequate intervention strategies and follow-up by the health care provider (HCP). The aims of the study are (i) to use a social marketing survey approach to understand the gaps in perceptions between patients with type 2 diabetes and HCPs on diabetes-related topics such as levels of awareness, use and satisfaction with community resources, and perceived barriers to self-management and (ii) to present the results of a public awareness campaign/diabetes management demonstration project (Cities for Life) on change in discordant views between HCPs and patients. The study was conducted as a separate sample pre–post quasiexperimental design study as part of a clinical-community program, Cities for Life in Birmingham, AL. The surveys were administered before (Wave 1 or W1 in 2012) and after (Wave 2 or W2 in 2013) implementation of the Cities for Life program. HCPs (n = 50 and 48) and patients with type 2 diabetes and prediabetes (n = 201 and 204) responded to surveys at W1 and W2, respectively. At both timepoints, HCPs and patients identified diabetes as a major health priority and stated education and information as the most valuable aspects of community-based programs (CBPs). Although 86% of HCPs reported recommending CBPs for lifestyle modification and that their patients frequently participated in CBPs (W1 = 70%; W2 = 82%), fewer patients reported participation (W1 = 31%; W2 = 22%). Patients frequently were not able to name any CBPs for diabetes prevention or treatment (W1 = 45%; W2 = 59%) despite a large proportion perceiving CBPs as valuable (W1 = 41%; W2 = 39%). A substantial percentage of patients reported receiving “a lot of support” from family/friends/or coworkers (W1 = 54%; W2 = 64%; p < .05), but HCPs believed that a much lower proportion of their patients received “a lot of support” (W1 = 0%, W2 = 10%, p < .05). Patients and HCPs independently reported patients’ lack of motivation as one of the main barriers to better diabetes care. HCPs and patients reported discordant views regarding two important aspects of diabetes self-management: the use of community resources and the degree of social suppor t received by patients. HCPs overestimated the patients’ use of community resources, and underestimated the patients’ degree of social support. Trans-disciplinary interventions to address patients’ lack of motivation and to engage social support networks may improve communication and mutual understanding about the role and benefits of community resources in diabetes and other chronic disease self-management.